In last trading session, Zura Bio Ltd (NASDAQ:ZURA) saw 0.42 million shares changing hands with its beta currently measuring 0.14. Company’s recent per share price level of $1.03 trading at -$0.06 or -5.07% at ring of the bell on the day assigns it a market valuation of $70.43M. That closing price of ZURA’s stock is at a discount of -516.5% from its 52-week high price of $6.35 and is indicating a premium of 4.85% from its 52-week low price of $0.98. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.38 million shares which gives us an average trading volume of 360.22K if we extend that period to 3-months.
For Zura Bio Ltd (ZURA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.29. Splitting up the data highlights that, out of 11 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 8 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
Zura Bio Ltd (NASDAQ:ZURA) trade information
Upright in the red during last session for losing -5.07%, in the last five days ZURA remained trading in the red while hitting it’s week-highest on Monday, 03/31/25 when the stock touched $1.03 price level, adding 23.68% to its value on the day. Zura Bio Ltd’s shares saw a change of -58.80% in year-to-date performance and have moved -18.58% in past 5-day. Zura Bio Ltd (NASDAQ:ZURA) showed a performance of -19.53% in past 30-days. Number of shares sold short was 5.31 million shares which calculate 21.89 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 15 to the stock, which implies a rise of 93.13% to its current value. Analysts have been projecting 15 as a low price target for the stock while placing it at a high target of 15. It follows that stock’s current price would drop -1356.31% in reaching the projected high whereas dropping to the targeted low would mean a loss of -1356.31% for stock’s current value.
In 2025, company’s earnings growth rate is likely to be around -12.38% while estimates for its earnings growth in next 5 years are of -15.63%.
Zura Bio Ltd (NASDAQ:ZURA)’s Major holders
Insiders are in possession of 27.51% of company’s total shares while institution are holding 59.96 percent of that, with stock having share float percentage of 82.71%. Investors also watch the number of corporate investors in a company very closely, which is 59.96% institutions for Zura Bio Ltd that are currently holding shares of the company. VR ADVISER, LLC is the top institutional holder at ZURA for having 6.02 million shares of worth $21.08 million. And as of 2024-06-30, it was holding 8.0365 of the company’s outstanding shares.
The second largest institutional holder is SUVRETTA CAPITAL MANAGEMENT, LLC, which was holding about 4.86 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.4858 of outstanding shares, having a total worth of $17.01 million.
On the other hand, iShares Trust-iShares Russell 2000 ETF and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025 , the former fund manager was holding 1.14 shares of worth $1.18 million or 1.67% of the total outstanding shares. The later fund manager was in possession of 500.32 shares on Dec 31, 2024 , making its stake of worth around $0.52 million in the company or a holder of 0.73% of company’s stock.
